title: Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels.
authors.forename: G
authors.initials: G
authors.lastname: Canovas
authors.forename: M
authors.initials: M
authors.lastname: León-Sanz
authors.forename: P
authors.initials: P
authors.lastname: Gómez
authors.forename: M A
authors.initials: MA
authors.lastname: Valero
authors.forename: P
authors.initials: P
authors.lastname: Gomis
authors.forename: J J
authors.initials: JJ
authors.lastname: La Huerta
mesh_terms: D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity; D001798:Blood Proteins / Q000187:drug effects; D003131:Combined Modality Therapy; D019587:Dietary Supplements; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D005973:Glutamine / Q000008:administration & dosage*; D019337:Hematologic Neoplasms / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D011446:Prospective Studies; D014182:Transplantation, Autologous
chemical_list: D001798:Blood Proteins; D005973:Glutamine